PerkinElmer stands to gain a number of array-related tools through its planned acquisition of Caliper Life Sciences.
The two companies last week said PerkinElmer would buy Caliper for $600 million in stock. The deal is expected to close before the end of the year.
While Caliper has never been a pure-play array firm, it does sell a menu of products that are widely used in microarray laboratories. These include instruments for sample preparation, liquid handling, and imaging.